Page 64 - Read Online
P. 64

Zhang et al. Cancer Drug Resist 2024;7:30                                        Cancer
               DOI: 10.20517/cdr.2024.62
                                                                                    Drug Resistance




               Review                                                                        Open Access



               The role of circRNAs and miRNAs in drug resistance
               and targeted therapy responses in breast cancer


                                                                     3
                                                                                                        1
                                                                                  3
                                           2
                                                                                              1
                           1
                                                          3
               Meilan Zhang , Zhaokuan Zheng , Shouliang Wang , Ruihan Liu , Mengli Zhang , Zhiyun Guo , Hao Wang ,
               Weige Tan 3
               1
                The Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou 511400, Guangdong, China.
               2
                Department of Orthopedics, Affiliated Huadu Hospital, Southern Medical University (People’s Hospital of HuaduDistrict),
               Guangzhou 510810, Guangdong, China.
               3
                Department of Breast Surgery, the First Affiliated Hospital, Guangzhou Medical University, Guangzhou 510120, Guangdong,
               China.
               Correspondence to: Prof. Zhiyun Guo, Prof. Hao Wang, The Affiliated Panyu Centra Hospital of Guangzhou Medical University,
               No. 8, Fuyu East Road, Qiaonan Street, Panyu District, Guangzhou 511400, Guangdong, China. E-mail: zhiyun2005@126.com;
               pyblk@hotmail.com; Prof. Weige Tan, Department of Breast Surgery, the First Affiliated Hospital, Guangzhou Medical University,
               No. 151, Yanjiang West Road, Yuexiu District, Guangzhou 510120, Guangdong, China. E-mail: tanweige@gzhmu.edu.cn
               How to cite this article: Zhang M, Zheng Z, Wang S, Liu R, Zhang M, Guo Z, Wang H, Tan W. The role of circRNAs and miRNAs
               in drug resistance and targeted therapy responses in breast cancer. Cancer Drug Resist 2024;7:30. https://dx.doi.org/10.20517/
               cdr.2024.62
               Received: 16 May 2024  First Decision: 4 Jul 2024  Revised: 20 Jul 2024  Accepted: 2 Aug 2024  Published: 20 Aug 2024

               Academic Editors: Mario Cioce, Hailin Tang  Copy Editor: Dong-Li Li  Production Editor: Dong-Li Li

               Abstract
               MicroRNAs (miRNAs) are small non-coding RNAs comprising 19-24 nucleotides that indirectly control gene
               expression. In contrast to other non-coding RNAs (ncRNAs), circular RNAs (circRNAs) are defined by their
               covalently closed loops, forming covalent bonds between the 3’ and 5’ ends. circRNAs regulate gene expression by
               interacting with miRNAs at transcriptional or post-transcriptional levels. Accordingly, circRNAs and miRNAs
               control many biological events related to cancer, including cell proliferation, metabolism, cell cycle, and apoptosis.
               Both circRNAs and miRNAs are involved in the pathogenesis of diseases, such as breast cancer. This review
               focuses on the latest discoveries on dysregulated circRNAs and miRNAs related to breast cancer, highlighting their
               potential as biomarkers for clinical diagnosis, prognosis, and chemotherapy response.

               Keywords: miRNAs, circRNAs, breast cancer, clinical values










                           © The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing,
                           adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as
               long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
               indicate if changes were made.

                                                                                        www.oaepublish.com/cdr
   59   60   61   62   63   64   65   66   67   68   69